Endocrinology, Diabetes, and Metabolism

SMJ Article | Original Article

New-Onset Type 2 Diabetes Mellitus in Critical Illness Survivors and after Hospitalization

Objectives: Recent literature suggests that hospitalization may lead to new-onset type 2 diabetes mellitus (NODM2). Understanding this relationship is crucial for developing interventions that could reduce long-term complications and healthcare costs associated with DM2 and major adverse cardiovascular events (MACE). This systematic review and meta-analysis aims to assess the incidence...

Posted in: Endocrinology, Diabetes, and Metabolism18

SMJ Article | Original Article

Improving Hypertension and Diabetes Mellitus Control with a Dedicated Patient Navigator

Objectives: Hypertension and diabetes mellitus (DM) are the leading causes of cardiovascular, cerebrovascular, and chronic kidney diseases. They affect an estimated 47% and 11% of Americans, respectively. In this study, we assessed whether a dedicated patient navigator embedded within a patient-centered medical home (PCMH) using a structured panel management and...

Posted in: Endocrinology, Diabetes, and Metabolism18 Hypertension10

SMJ Article | Original Article

Predictors of Blood Transfusion in Patients Undergoing Cytoreductive Surgeries for Ovarian Malignancy

Objectives: The aims of this study were to describe the baseline estimated blood loss (EBL) in surgery and transfusion rate in patients undergoing cytoreductive surgeries for ovarian malignancy, and identify perioperative variables associated with blood loss and transfusion. Methods: A retrospective cohort study at a single institution was performed that...

Posted in: Ovarian Disorders And Female Reproductive Health3 Ovarian Disorders3

SMJ Article | Perspectives

Know Your Guidelines Series: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of liver disease without ongoing or significant alcohol use that ranges from hepatic steatosis to cirrhosis. NAFLD is associated with obesity, insulin resistance, type 2 diabetes mellitus (T2DM), hypertension, and dyslipidemia.1,2 Nonalcoholic steatohepatitis (NASH) represents the progression of NAFLD with at least...

Posted in: Endocrinology, Diabetes, and Metabolism18

SMJ Article | Original Article

Type 2 Diabetes Mellitus and Helicobacter pylori Eradication in a Clinical Population

Objectives: Eradication of Helicobacter pylori reduces the risk of gastric cancer (GC). Individuals with type 2 diabetes mellitus (T2DM) are known to be at increased risk for GC. In a cohort of H. pylori-positive individuals, we assessed whether those with T2DM were at risk of persistent infection following H. pylori...

Posted in: Endocrinology, Diabetes, and Metabolism18

Abstract | November 17, 2023

Maternal Cardiac Arrest Secondary to an Avulsion of the Ovarian Vein from the Inferior Vena Cava ian vein from the inferior vena cava.

We present a case of a patient who underwent cardiac arrest in the immediate postpartum period secondary to an avulsion of the right ovarian vein from the inferior vena cava (IVC).

Posted in: Women’s Health Endocrine Issues2

Abstract | November 17, 2023

Clinical Presentation of Usher Syndrome Type 1B (USH1B) in a 10-Month-Old Infant: A Case Report

Usher Syndrome is a genetically inherited condition characterized by congenital sensorineural hearing loss as well as progressive vision loss secondary to retinitis pigmentosa.

Posted in: Women’s Health Endocrine Issues2

SMJ Article | Review Article

A Comprehensive Review of COVID-19–Associated Endocrine Manifestations

Coronavirus disease 2019 (COVID-19) has played a significant part in systematic damage, affecting lives and leading to significant mortality. The endocrine system is one of the systems affected by this pandemic outbreak. The relationship between them has been identified in previous and ongoing research. The mechanism through which severe acute...

Posted in: Endocrinology, Diabetes, and Metabolism18 Infectious Disease140

SMJ Article | Original Article

Retrospective Analysis of Hospitalized Patients with Type 2 Diabetes Mellitus Treated with Glucagon-Like Peptide 1 Receptor Agonist Therapy

 Objectives: The use and overall benefit of glucagon-like peptide-1 (GLP-1) receptor agonist therapy for hospitalized patients with type 2 diabetes mellitus (DM) with chronic kidney disease (CKD) has limited data regarding impact and safety. We studied the impact and safety of GLP-1 receptor agonist therapy in hospitalized DM patients with...

Posted in: Endocrinology, Diabetes, and Metabolism18

Load More Content

SMA Menu